Translink Corporate Finance advised the owners of Mathot on the sale to Mediq

Translink Corporate Finance Denmark acted as M&A advisor to the shareholders of Mathot on its sale to Mediq.

The cross-border team, led by Henrik Schrøder and Jens Borelli-Kjaer from Denmark and Thomas Hesseling from the Netherlands, acted as M&A advisor to the shareholders of Mathot on its sale to Mediq. Mediq is a trusted partner to patients, healthcare providers and health insurers, with a strong focus on improving healthcare outcomes while enhancing the affordability of healthcare.

Accelerating growth to enhance affordable and future-proof medical care
The acquisition of Mathot, a supplier of medical devices and a specialist in ostomy care, wound care, continence care and compression therapy, marks another important step in Mediq’s growth strategy. The transaction strengthens Mediq’s ambition to continue providing high-quality medical device care in the years ahead. It is fully aligned with Mediq’s mission to keep healthcare affordable and accessible. By combining the two businesses, the acquisition creates economies of scale, ensures continuity of care, and helps meet growing demand while maintaining and where possible further enhancing the quality of care.

Comments from Mediq
Marcia Luijendijk, Benelux General Manager at Mediq, said, “By leveraging economies of scale and combining our expertise, we can contribute even better to improving the quality of life of patients and relieving the burden on healthcare professionals. We are delighted to be able to add expert people to our team and to join forces to provide the right care to patients and healthcare professionals, both now and in the future.”